Adalimumab induced chilblain lupus in a patient with rheumatoid arthritis

Dermatol Ther. 2020 Jul;33(4):e13764. doi: 10.1111/dth.13764. Epub 2020 Jul 11.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adalimumab / adverse effects
  • Antirheumatic Agents* / adverse effects
  • Arthritis, Rheumatoid* / diagnosis
  • Arthritis, Rheumatoid* / drug therapy
  • Chilblains* / chemically induced
  • Chilblains* / diagnosis
  • Humans
  • Lupus Erythematosus, Cutaneous* / chemically induced
  • Lupus Erythematosus, Cutaneous* / diagnosis
  • Lupus Erythematosus, Cutaneous* / drug therapy

Substances

  • Antirheumatic Agents
  • Adalimumab

Supplementary concepts

  • Chilblain lupus 1